Target Name: MIR6843
NCBI ID: G102465508
Review Report on MIR6843 Target / Biomarker Content of Review Report on MIR6843 Target / Biomarker
MIR6843
Other Name(s): MicroRNA 6843 | microRNA 6843 | hsa-miR-6843-3p | hsa-mir-6843

miRNA 6843: A Non-Coding RNA Molecule with Potential Drug Targets and Biomarkers

MicroRNA (miRNA) 6843 is a non-coding RNA molecule that plays a crucial role in regulating gene expression in various organisms, including humans. Mammalian miRNA 6843 is a small non-coding RNA molecule, approximately 20-22nt in length. It is expressed in various cell types of the human body and the function of this RNA molecule is still not well understood.

Recent studies have identified miRNA 6843 as a potential drug target and a biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. miRNA 6843 has been shown to play a role in regulating the expression of genes involved in cell growth, apoptosis, and inflammation.

One of the key functions of miRNA 6843 is its ability to target specific mRNAs for degradation. This process is known as post-transcriptional modification (PTM) and it is a well-established mechanism for regulating gene expression in various cell types. PTMs play a crucial role in the regulation of gene expression and can alter the stability and translation efficiency of mRNAs.

Studies have shown that miRNA 6843 can interact with several protein partners, including the RNA-protein complex known as double-stranded RNA viruses (dsRVs). These interactions can alter the stability and translation efficiency of mRNAs and may have implications for the regulation of various cellular processes.

Another function of miRNA 6843 is its role in cell apoptosis. Apoptosis is a natural process that is involved in the regulation of cell life cycle and it is a mechanism for removing damaged or dysfunctional cells. MiRNA 6843 has been shown to play a role in the regulation of cell apoptosis by targeting several genes involved in cell death signaling pathways.

In addition to its role in cell apoptosis, miRNA 6843 has also been shown to play a role in the regulation of cell proliferation. miRNA 6843 has been shown to target genes involved in cell cycle progression and cell proliferation, leading to the regulation of cell growth and the inhibition of cell proliferation.

The potential drug targets for miRNA 6843 include the regulation of cell apoptosis, the regulation of cell proliferation, and the regulation of gene expression involved in cell growth and inflammation. miRNA 6843 may also be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders.

In conclusion, miRNA 6843 is a non-coding RNA molecule that plays a crucial role in regulating gene expression in various cell types. Its functions include the regulation of cell apoptosis, the regulation of cell proliferation, and the regulation of gene expression involved in cell growth and inflammation. The potential drug targets for miRNA 6843 include the regulation of cell apoptosis, the regulation of cell proliferation, and the regulation of gene expression involved in cell growth and inflammation. Furthermore, miRNA 6843 may be used as a biomarker for various diseases, including cancer, neurodegenerative diseases, and metabolic disorders. Further studies are needed to fully understand the functions of miRNA 6843 and its potential as a drug target and biomarker.

Protein Name: MicroRNA 6843

The "MIR6843 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR6843 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR6844 | MIR6845 | MIR6846 | MIR6847 | MIR6848 | MIR6849 | MIR6850 | MIR6851 | MIR6852 | MIR6853 | MIR6854 | MIR6855 | MIR6856 | MIR6857 | MIR6858 | MIR6859-1 | MIR6859-2 | MIR6859-3 | MIR6859-4 | MIR6860 | MIR6861 | MIR6862-1 | MIR6862-2 | MIR6863 | MIR6864 | MIR6865 | MIR6866 | MIR6867 | MIR6868 | MIR6869 | MIR6870 | MIR6871 | MIR6872 | MIR6873 | MIR6874 | MIR6875 | MIR6876 | MIR6877 | MIR6878 | MIR6879 | MIR6880 | MIR6881 | MIR6882 | MIR6883 | MIR6884 | MIR6885 | MIR6886 | MIR6887 | MIR6888 | MIR6889 | MIR6890 | MIR6891 | MIR6892 | MIR6893 | MIR6894 | MIR6895 | MIR7-1 | MIR7-2 | MIR7-3 | MIR7-3HG | MIR708 | MIR7106 | MIR7107 | MIR7108 | MIR7109 | MIR711 | MIR7110 | MIR7111 | MIR7112 | MIR7113 | MIR7114 | MIR7150 | MIR7151 | MIR7152 | MIR7153 | MIR7154 | MIR7155 | MIR7156 | MIR7158 | MIR7159 | MIR7160 | MIR7161 | MIR7162 | MIR718 | MIR720 | MIR744 | MIR7515 | MIR758 | MIR759 | MIR760 | MIR761 | MIR762 | MIR762HG | MIR764 | MIR765 | MIR766 | MIR767 | MIR769 | MIR770 | MIR7702